OcuTerra Therapeutics
PrivateCompany Overview
OcuTerra Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. It was founded in 2020.
OcuTerra Therapeutics is a biotechnology company that developed non-invasive eye drop treatments for diabetic eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OcuTerra Therapeutics Comparables
Compare OcuTerra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exonate | 85% | |
| Panoptica | 84% | |
| Retinset, S.L. | 82% |
For institutional investors. Book with your work email.
OcuTerra Therapeutics Funding Rounds
Historical fundraising activity
OcuTerra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OcuTerra Therapeutics's valuation, stock price, and market status.
Is OcuTerra Therapeutics a public or private company?
OcuTerra Therapeutics is a private company.
What is the current stock price of OcuTerra Therapeutics?
OcuTerra Therapeutics is a private company, so its shares have no public market price. Caplight tracks OcuTerra Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OcuTerra Therapeutics worth (valuation)?
Valuation information for OcuTerra Therapeutics is not publicly available.
Can I buy OcuTerra Therapeutics stock?
OcuTerra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OcuTerra Therapeutics's last funding round?
Funding round information for OcuTerra Therapeutics is not publicly available.
Who are the main investors in OcuTerra Therapeutics?
Investor information for OcuTerra Therapeutics is not publicly disclosed.
Will OcuTerra Therapeutics IPO soon?
No public IPO plans have been announced for OcuTerra Therapeutics.
How can I track OcuTerra Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in OcuTerra Therapeutics's shares on secondary markets.